These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 22151792)

  • 21. Human immunodeficiency virus type 1 resistance to the small molecule maturation inhibitor 3-O-(3',3'-dimethylsuccinyl)-betulinic acid is conferred by a variety of single amino acid substitutions at the CA-SP1 cleavage site in Gag.
    Zhou J; Chen CH; Aiken C
    J Virol; 2006 Dec; 80(24):12095-101. PubMed ID: 17035324
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HIV-1 Gag processing intermediates trans-dominantly interfere with HIV-1 infectivity.
    Müller B; Anders M; Akiyama H; Welsch S; Glass B; Nikovics K; Clavel F; Tervo HM; Keppler OT; Kräusslich HG
    J Biol Chem; 2009 Oct; 284(43):29692-703. PubMed ID: 19666477
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structure-Activity Relationships of the Human Immunodeficiency Virus Type 1 Maturation Inhibitor PF-46396.
    Murgatroyd C; Pirrie L; Tran F; Smith TK; Westwood NJ; Adamson CS
    J Virol; 2016 Sep; 90(18):8181-97. PubMed ID: 27384665
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High prevalence of bevirimat resistance mutations in protease inhibitor-resistant HIV isolates.
    Verheyen J; Verhofstede C; Knops E; Vandekerckhove L; Fun A; Brunen D; Dauwe K; Wensing AM; Pfister H; Kaiser R; Nijhuis M
    AIDS; 2010 Mar; 24(5):669-73. PubMed ID: 19926962
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Insights into the activity of maturation inhibitor PF-46396 on HIV-1 clade C.
    Ghimire D; Timilsina U; Srivastava TP; Gaur R
    Sci Rep; 2017 Mar; 7():43711. PubMed ID: 28252110
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MicroED structures of HIV-1 Gag CTD-SP1 reveal binding interactions with the maturation inhibitor bevirimat.
    Purdy MD; Shi D; Chrustowicz J; Hattne J; Gonen T; Yeager M
    Proc Natl Acad Sci U S A; 2018 Dec; 115(52):13258-13263. PubMed ID: 30530702
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of human immunodeficiency virus type 1 resistance to protease inhibitors on evolution of resistance to the maturation inhibitor bevirimat (PA-457).
    Adamson CS; Waki K; Ablan SD; Salzwedel K; Freed EO
    J Virol; 2009 May; 83(10):4884-94. PubMed ID: 19279107
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro selection of clinically relevant bevirimat resistance mutations revealed by "deep" sequencing of serially passaged, quasispecies-containing recombinant HIV-1.
    Knapp DJ; Harrigan PR; Poon AF; Brumme ZL; Brockman M; Cheung PK
    J Clin Microbiol; 2011 Jan; 49(1):201-8. PubMed ID: 21084518
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phase I and II study of the safety, virologic effect, and pharmacokinetics/pharmacodynamics of single-dose 3-o-(3',3'-dimethylsuccinyl)betulinic acid (bevirimat) against human immunodeficiency virus infection.
    Smith PF; Ogundele A; Forrest A; Wilton J; Salzwedel K; Doto J; Allaway GP; Martin DE
    Antimicrob Agents Chemother; 2007 Oct; 51(10):3574-81. PubMed ID: 17638699
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Construction of a HIV-1 subtype C 3D model using homology modeling and in-silico docking, molecular dynamics simulation, and MM-GBSA calculation of second-generation HIV-1 maturation inhibitor(s).
    K C Y; Pal S; Nitz TJ; Wild C; Gaur R
    J Biomol Struct Dyn; 2024 Sep; 42(14):7150-7159. PubMed ID: 37489057
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A single polymorphism in HIV-1 subtype C SP1 is sufficient to confer natural resistance to the maturation inhibitor bevirimat.
    Lu W; Salzwedel K; Wang D; Chakravarty S; Freed EO; Wild CT; Li F
    Antimicrob Agents Chemother; 2011 Jul; 55(7):3324-9. PubMed ID: 21502630
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Susceptibility of human immunodeficiency virus type 1 to the maturation inhibitor bevirimat is modulated by baseline polymorphisms in Gag spacer peptide 1.
    Van Baelen K; Salzwedel K; Rondelez E; Van Eygen V; De Vos S; Verheyen A; Steegen K; Verlinden Y; Allaway GP; Stuyver LJ
    Antimicrob Agents Chemother; 2009 May; 53(5):2185-8. PubMed ID: 19223634
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HIV-1 Maturation: Lessons Learned from Inhibitors.
    Kleinpeter AB; Freed EO
    Viruses; 2020 Aug; 12(9):. PubMed ID: 32858867
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Maturation inhibitors: a new therapeutic class targets the virus structure.
    Salzwedel K; Martin DE; Sakalian M
    AIDS Rev; 2007; 9(3):162-72. PubMed ID: 17982941
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New betulinic acid derivatives for bevirimat-resistant human immunodeficiency virus type-1.
    Dang Z; Ho P; Zhu L; Qian K; Lee KH; Huang L; Chen CH
    J Med Chem; 2013 Mar; 56(5):2029-37. PubMed ID: 23379607
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phosphate Derivatives of 3-Carboxyacylbetulin: SynThesis, In Vitro Anti-HIV and Molecular Docking Study.
    Marciniec K; Chrobak E; Dąbrowska A; Bębenek E; Kadela-Tomanek M; Pęcak P; Boryczka S
    Biomolecules; 2020 Aug; 10(8):. PubMed ID: 32764519
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Incorporation of Privileged Structures into Bevirimat Can Improve Activity against Wild-Type and Bevirimat-Resistant HIV-1.
    Zhao Y; Gu Q; Morris-Natschke SL; Chen CH; Lee KH
    J Med Chem; 2016 Oct; 59(19):9262-9268. PubMed ID: 27676157
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Primary genotypic resistance of HIV-1 to the maturation inhibitor PA-457 in protease inhibitor-experienced patients.
    Malet I; Wirden M; Derache A; Simon A; Katlama C; Calvez V; Marcelin AG
    AIDS; 2007 Apr; 21(7):871-3. PubMed ID: 17415044
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The maturation inhibitor bevirimat (PA-457) can be active in patients carrying HIV type-1 non-B subtypes and recombinants.
    Yebra G; Holguín A
    Antivir Ther; 2008; 13(8):1083-5. PubMed ID: 19195334
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of an HIV-1 Mutation in Spacer Peptide 1 That Stabilizes the Immature CA-SP1 Lattice.
    Fontana J; Keller PW; Urano E; Ablan SD; Steven AC; Freed EO
    J Virol; 2016 Jan; 90(2):972-8. PubMed ID: 26537676
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.